ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bruceae Fructus Oil Inhibits Triple-Negative Breast Cancer by Restraining Autophagy: Dependence on the Gut Microbiota-Mediated Amino Acid Regulation

Su, Jiyan; Chen, Xiaohong; Xiao, Yuanjie; Li, Dan; Li, Muxia; Li, Hongfu; Huang, Jiangjian; Lai, Zhengquan; Su, Ziren; Xie, Yizhen; Zhu, Dajiang; Chen, Qianjun; Lu, Hai; He, Jingjin*; Xia, Chenglai*广东省人民医院; 广东省微生物研究所; 广州中医药大学; 南方医科大学; 中山大学
Frontiers in Pharmacology2021-10-1DOI: 10.3389/fphar.2021.727082
9被引6阅读
引用收藏
分享

摘要

Triple-negative breast cancer (TNBC) has been acknowledged as an aggressive disease with worst prognosis, which requires endeavor to develop novel therapeutic agents. Bruceae fructus oil (BO), a vegetable oil derived from the fruit of Brucea javanica (L.) Merr., is an approved marketable drug for the treatment of cancer in China for several decades. Despite that the anti-breast cancer activity of several quassinoids derived from B. javanica has been found, it was the first time that the potential of BO against TNBC was revealed. Although BO had no cytotoxicity on TNBC cell lines in vitro, the oral administration of BO exhibited a gut microbiota-dependent tumor suppression without toxicity on the non-targeted organs in vivo. By metagenomics and untargeted metabolomics, it was found that BO not only altered the composition and amino acid metabolism function of gut microbiota but also regulated the host's amino acid profile, which was in accordance with the metabolism alternation in gut microbiota. Moreover, the activity of mTOR in tumor was promoted by BO treatment as indicated by the phosphorylation of 4E-binding protein 1 (4E-BP1) and ribosomal protein S6, and hyper-autophagy was consequently restrained. By contrast, the failure of tumor suppression by BO under pseudo germ-free (PGF) condition came with indistinctive changes in autophagy and mTOR activity, implying the critical role of the gut microbiota in BO's anticancer activity. The present study highlighted a promising application of BO against breast cancer with novel efficacy and safety.

学科与关键词

关键词
Bruceae fructus oiltriple-negative breast cancergut microbiotaamino acid metabolismautophagymTOR
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-10-01
卷期
第 12 卷
页码
727082
DOI
10.3389/fphar.2021.727082
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81902709, 81900238, 81974571]; China Postdoctoral Science Foundation [2018M643300, 2020M682683]; Natural Science Foundation of Guangdong [2018A0303130102, 2019A1515010815]; Science and Technology Bureau of Foshan [FS0AA-KJ218-1301-0008, FS0AA-KJ819-4901-0082]; Foshan Medicine Dengfeng Project of China; Science and Technology Planning Project of Shenzhen City [JCYJ20190808114807611]

作者

  • S

    Su, Jiyan (第一作者)

    southern med univ

  • C

    Chen, Xiaohong

    xiamen med coll · guangdong inst microbiol

查看全部 15 位作者收起作者
  • X

    Xiao, Yuanjie

  • L

    Li, Dan

    guangzhou univ chinese med

  • L

    Li, Muxia

    guangzhou univ chinese med

  • L

    Li, Hongfu

    sun yat sen univ

  • H

    Huang, Jiangjian

  • L

    Lai, Zhengquan

    shenzhen univ

  • S

    Su, Ziren

    guangzhou univ chinese med

  • X

    Xie, Yizhen

    guangdong inst microbiol

  • Z

    Zhu, Dajiang

    southern med univ

  • C

    Chen, Qianjun

    guangdong prov hosp

  • L

    Lu, Hai

    guangdong prov hosp

  • H

    He, Jingjin (通讯)

    sun yat sen univ

  • X

    Xia, Chenglai (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417